This study will help to better understand the course of disease in people with haemophilia (A or B \[with or without inhibitors\]) and the haemophilia care scenario in the selected countries and the experience so far in dealing with the condition. This is a survey-based study; hence no medications or other treatments will be provided to participants as a part of this study.
Study Type
OBSERVATIONAL
Enrollment
244
No treatment given
Novo Nordisk Investigational Site
Bangalore, Karnataka, India
Novo Nordisk Investigational Site
Kuala Lumpur, Malaysia
Novo Nordisk Investigational Site
Seoul, South Korea
Novo Nordisk Investigational Site
Bangkok, Thailand
Estimated prevalence of haemophilia
Proportion \[%\] of individuals in a population
Time frame: From start of data collection to end of data collection (approximately 5 months)
Estimated incidence of haemophilia
Number of new cases of haemophilia
Time frame: From start of data collection to end of data collection (approximately 5 months)
Estimated proportion of patients with haemophilia (PWH) who develop inhibitors (%)
proportion \[%\] of individuals in a population
Time frame: From start of data collection to end of data collection (approximately 5 months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.